AMWL

American Well Corporation AMWL

$13.23 +2.28 (+20.82%)

Blow-off · +4.41σ Hot zone Grade C

+ Compare Open in Sniper

Price chart

Timeframe

Range

Loading…

Latest bar · AMWL

Momentum reads · latest daily bar

Last

$13.23

+2.28 (+20.82%)

Mkt cap

$221M

Healthcare

RSI(14)

81.3

overbought

Stochastic %K

90.1

overbought

MFI(14)

91.6

overbought

ADX(14)

40.1

trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

Quarter	Revenue	Net income	Op income	FCF	Net margin	Op margin
2026-03-31	$0.1B	$-0.0B	$-0.0B	$-0.0B	-19.8%	-31.7%
2025-12-31	$0.1B	$-0.0B	$-0.0B	$-0.0B	-45.1%	-45.5%
2025-09-30	$0.1B	$-0.0B	$-0.0B	$-0.0B	-57.5%	-52.1%
2025-06-30	$0.1B	$-0.0B	$-0.0B	$-0.0B	-27.8%	-28.7%
2025-03-31	$0.1B	$-0.0B	$-0.0B	$-0.0B	-28.0%	-45.5%
2024-12-31	$nanB	$nanB	$nanB	$nanB	nan%	nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare AMWL vs peers

Line AMWL up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing AMWL MSFT× JNJ× ABBV×

Sector peers + LLY + UNH + MRK + PFE + TMO

Popular + AAPL + NVDA + AMZN + GOOG + META + TSLA + AVGO

Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Verdict

Weighted score 0-100 across 4 tickers · best in green

AMWL

score 57.1

2/5 inputs

Ranks second purely on explosive momentum at 100/100 with 172.78% YTD gain despite zero sentiment score.

momentum 100sentiment 0

MSFT

score 58.3

5/5 inputs

Takes first with perfect growth score of 100 from 18.3% revenue and 23.4% EPS expansion offsetting zero momentum.

value 33growth 100quality 67momentum 0sentiment 100

JNJ

score 51.5

3/5 inputs

Ranks third with balanced quality at 63 and sentiment at 67 but lacks any value or growth data.

quality 63momentum 31sentiment 67

ABBV

score 31.5

5/5 inputs

Falls to fourth on zero growth score driven by negative 46.2% EPS decline despite strong 67 value rating.

value 67growth 0quality 25momentum 39sentiment 22

Metric	AMWL AMWL	MSFT Microsoft Corporation	JNJ JNJ	ABBV AbbVie Inc.
Snapshot
Price	13.23	393.82	253.04	254.49
Day %↕	20.82	-1.82	1.23	0.04
1M %↕	53.48	-0.0	7.59	14.39
3M %↕	113.73	-6.29	7.89	21.77
YTD %↕	172.78	-16.73	22.04	10.98
Market cap	—	2925466222592.0	—	449631125504.0
ADV ($)	—	15501831798.361267	—	1818746671.4276276
Beta	—	1.13	—	0.283
OdysseyHQ zone
Current zone	Blow-off	Neutral	Neutral	Extended
Dist 21-EMA %	33.55	1.16	0.93	3.95
Dist ATR (σ)	4.41	0.37	0.38	1.46
OdysseyHQ grade	C	—	—	—
Confluence↕	3	0	1	2
Valuation
P/E (ttm)↕	—	23.469606	—	124.75001
P/E (fwd)↕	—	20.324642	—	15.63166
P/S↕	—	9.191689	—	7.1575656
EV/EBITDA↕	—	16.116	—	17.155
P/B↕	—	7.0606165	—	-67.55774
FCF yield↕	—	0.0127	—	0.0463
PEG↕	—	1.21	—	0.42
Growth
Revenue yoy↕	—	0.183	—	0.124
EPS yoy↕	—	0.234	—	-0.462
FCF yoy↕	—	—	—	—
Revenue trend 8Q
Quality
Gross margin↕	—	0.68309	—	0.72026
Operating margin↕	—	0.46326	—	0.32156
Net margin↕	—	0.39341998	—	0.05786
ROE↕	—	0.34013999	—	—
ROA↕	—	0.14814	—	0.10032
Debt / Equity↕	—	0.3	—	—
Interest cov.↕	—	52.84	34.55	3.28
Technicals
RSI(14)	81.3	51.9	54.4	64.3
MACD signal	bull	neutral	neutral	neutral
vs 50-DMA	49.56	-1.92	6.03	11.56
vs 200-DMA	118.21	-10.36	13.51	13.87
vs 52w high	-0.15	-29.1	-6.08	-2.73
HV-30	81.2	34.3	29.3	34.6
Sentiment
Analyst rec↕	—	1.31579	—	1.74194
Target upside↕	—	41.74	—	4.75
Insider buy-sell 90d↕	-1	20	13	13
Risk
Short interest↕	—	1.2	—	1.38
Days to cover↕	—	1.84	—	2.52
Next earnings	—	2026-07-29	—	2026-07-31

AMWL

$13.23

+20.82%

Snapshot

Price 13.23

Day % 20.82

1M % 53.48

3M % 113.73

YTD % 172.78

Market cap —

ADV ($) —

Beta —

OdysseyHQ zone

Current zone Blow-off

Dist 21-EMA % 33.55

Dist ATR (σ) 4.41

OdysseyHQ grade C

Confluence 3

Valuation

P/E (ttm) —

P/E (fwd) —

P/S —

EV/EBITDA —

P/B —

FCF yield —

PEG —

Growth

Revenue yoy —

EPS yoy —

FCF yoy —

Revenue trend 8Q

Quality

Gross margin —

Operating margin —

Net margin —

ROE —

ROA —

Debt / Equity —

Interest cov. —

Technicals

RSI(14) 81.3

MACD signal bull

vs 50-DMA 49.56

vs 200-DMA 118.21

vs 52w high -0.15

HV-30 81.2

Sentiment

Analyst rec —

Target upside —

Insider buy-sell 90d -1

Risk

Short interest —

Days to cover —

Next earnings —

Full AMWL dashboard →

MSFT

Microsoft Corporation

$393.82

-1.82%

Snapshot

Price 393.82

Day % -1.82

1M % -0.0

3M % -6.29

YTD % -16.73

Market cap 2925466222592.0

ADV ($) 15501831798.361267

Beta 1.13

OdysseyHQ zone

Current zone Neutral

Dist 21-EMA % 1.16

Dist ATR (σ) 0.37

OdysseyHQ grade —

Confluence 0

Valuation

P/E (ttm) 23.469606

P/E (fwd) 20.324642

P/S 9.191689

EV/EBITDA 16.116

P/B 7.0606165

FCF yield 0.0127

PEG 1.21

Growth

Revenue yoy 0.183

EPS yoy 0.234

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.68309

Operating margin 0.46326

Net margin 0.39341998

ROE 0.34013999

ROA 0.14814

Debt / Equity 0.3

Interest cov. 52.84

Technicals

RSI(14) 51.9

MACD signal neutral

vs 50-DMA -1.92

vs 200-DMA -10.36

vs 52w high -29.1

HV-30 34.3

Sentiment

Analyst rec 1.31579

Target upside 41.74

Insider buy-sell 90d 20

Risk

Short interest 1.2

Days to cover 1.84

Next earnings 2026-07-29

Full MSFT dashboard →

JNJ

$253.04

+1.23%

Snapshot

Price 253.04

Day % 1.23

1M % 7.59

3M % 7.89

YTD % 22.04

Market cap —

ADV ($) —

Beta —

OdysseyHQ zone

Current zone Neutral

Dist 21-EMA % 0.93

Dist ATR (σ) 0.38

OdysseyHQ grade —

Confluence 1

Valuation

P/E (ttm) —

P/E (fwd) —

P/S —

EV/EBITDA —

P/B —

FCF yield —

PEG —

Growth

Revenue yoy —

EPS yoy —

FCF yoy —

Revenue trend 8Q

Quality

Gross margin —

Operating margin —

Net margin —

ROE —

ROA —

Debt / Equity —

Interest cov. 34.55

Technicals

RSI(14) 54.4

MACD signal neutral

vs 50-DMA 6.03

vs 200-DMA 13.51

vs 52w high -6.08

HV-30 29.3

Sentiment

Analyst rec —

Target upside —

Insider buy-sell 90d 13

Risk

Short interest —

Days to cover —

Next earnings —

Full JNJ dashboard →

ABBV

AbbVie Inc.

$254.49

+0.04%

Snapshot

Price 254.49

Day % 0.04

1M % 14.39

3M % 21.77

YTD % 10.98

Market cap 449631125504.0

ADV ($) 1818746671.4276276

Beta 0.283

OdysseyHQ zone

Current zone Extended

Dist 21-EMA % 3.95

Dist ATR (σ) 1.46

OdysseyHQ grade —

Confluence 2

Valuation

P/E (ttm) 124.75001

P/E (fwd) 15.63166

P/S 7.1575656

EV/EBITDA 17.155

P/B -67.55774

FCF yield 0.0463

PEG 0.42

Growth

Revenue yoy 0.124

EPS yoy -0.462

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.72026

Operating margin 0.32156

Net margin 0.05786

ROE —

ROA 0.10032

Debt / Equity —

Interest cov. 3.28

Technicals

RSI(14) 64.3

MACD signal neutral

vs 50-DMA 11.56

vs 200-DMA 13.87

vs 52w high -2.73

HV-30 34.6

Sentiment

Analyst rec 1.74194

Target upside 4.75

Insider buy-sell 90d 13

Risk

Short interest 1.38

Days to cover 2.52

Next earnings 2026-07-31

Full ABBV dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

Date	EPS actual	EPS est	Surprise	Next-day
2026-05-05	-0.67	-0.77	+12.9%	+12.4%
2026-02-12	-1.12	-1.59	+29.5%	+24.7%
2025-11-04	-1.55	-1.46	-6.5%	-9.5%
2025-08-05	-0.72	-1.11	+34.9%	-7.3%
2025-05-01	-1.17	-1.88	+38.0%	+19.7%
2025-02-12	-1.96	-2.55	+23.4%	-5.0%
2024-10-30	-2.29	-3.11	+26.1%	-5.1%
2024-07-31	-2.68	-3.40	+21.0%	+40.2%
2024-05-01	-0.17	-3.41	+95.0%	-2.1%
2024-02-14	-2.51	-3.30	+23.9%	+18.0%
2023-11-01	-2.74	-3.62	+24.3%	+13.6%
2023-08-02	-3.19	-3.72	+14.2%	-5.0%
2023-05-03	-3.68	-3.48	-6.0%	-6.1%
2023-02-22	-2.14	-4.40	+51.4%	-13.8%
2022-11-07	-3.36	-4.19	+19.7%	-3.8%
2022-08-04	-4.66	-4.21	-10.7%	+7.5%
2022-05-09	-3.97	-4.02	+1.5%	-3.7%
2022-02-24	-3.57	-4.62	+22.7%	-0.7%
2021-11-10	-3.46	-4.30	+19.7%	-6.2%
2021-08-11	-2.92	-3.51	+16.8%	+4.6%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅	Mkt cap ⇅	P/E ⇅	Fwd P/E ⇅	P/S ⇅	EV/EBITDA ⇅	P/B ⇅	Gross M ⇅	Rev gr ⇅	EPS gr ⇅	FCF yld ⇅
AMWL ★	$0B	—	-7.9	0.9	-1.2	1.0	53.8%	-17.9%	—	-5.33%
LLY	$1,051B	41.8	26.3	14.6	30.1	33.8	82.8%	55.5%	169.9%	0.87%
UNH	$387B	32.1	19.2	0.9	17.7	4.0	19.5%	0.4%	61.5%	5.88%
JNJ	$609B	29.3	19.7	6.2	18.4	7.5	68.1%	6.6%	-1.0%	—
MRK	$315B	36.0	13.2	4.8	12.1	6.9	76.7%	4.9%	—	4.46%
ABBV	$450B	124.8	15.6	7.2	17.2	-67.6	72.0%	12.4%	-46.2%	4.63%
PFE	$143B	19.1	8.8	2.3	7.6	1.6	74.8%	5.4%	-10.1%	8.67%
TMO	$198B	29.2	19.5	4.4	21.1	3.8	40.9%	6.2%	11.3%	2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 35.28%

Holder	Shares	% out
Morgan Stanley	1,156,453	7.68%
Senvest Management LLC	1,136,558	7.55%
Cable Car Capital, LP	1,002,650	6.66%
Vanguard Capital Management LLC	567,271	3.77%
Acadian Asset Management. LLC	406,622	2.70%
Blackrock Inc.	391,379	2.60%
Renaissance Technologies, LLC	195,023	1.29%
Geode Capital Management, LLC	188,372	1.25%
Rock Point Advisors, LLC	136,086	0.90%
Two Sigma Investments, LP	133,009	0.88%

Insider activity · 90d

7 buys / 8 sells · ratio 0.88 · Finnhub

McNeice Paul Francis SELL 9,851 @ $9.33
Zamansky Dmitry SELL 232,620 @ $9.33
Gotlib Phyllis SELL 152,754 @ $9.33
HIRSCHHORN MARK SELL 238,939 @ $9.33
Cosgrove Delos M. BUY 71,193
Webb Robert Thomas BUY 72,559
Ross Derek BUY 71,183
Goldwasser Rivka BUY 105,861
Schlegel Stephen J. BUY 69,054
Jackson Deborah C BUY 53,633

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low

$6.5

Mean

$8.9

High

$16.0

Analysts

Recommendation distribution · period 2026-07-01

Revision trend (2026-04-01 → 2026-07-01): net 6 → 6 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

Form	Filed	Description	Action
8-K	2026-07-14	8-K	view ·
4	2026-07-01	4	view ·
4	2026-07-01	4	view ·
4	2026-07-01	4	view ·
4	2026-07-01	4	view ·
8-K	2026-06-22	8-K	view ·
4	2026-06-18	4	view ·
4	2026-06-18	4	view ·
4	2026-06-18	4	view ·
4	2026-06-18	4	view ·
4	2026-06-18	4	view ·
4	2026-06-18	4	view ·
4	2026-06-15	4	view ·
4	2026-06-03	4	view ·
4	2026-06-03	4	view ·
4	2026-06-03	4	view ·
8-K	2026-05-12	8-K	view ·
4	2026-05-11	4	view ·
10-Q	2026-05-05	10-Q	view ·
8-K	2026-05-05	8-K	view ·
DEF 14A	2026-04-23	DEF 14A	view ·
4	2026-04-02	4	view ·
4	2026-04-02	4	view ·
4	2026-04-02	4	view ·
8-K	2026-04-02	8-K	view ·
4	2026-03-06	4	view ·
4	2026-03-06	4	view ·
4	2026-03-06	4	view ·
4	2026-03-06	4	view ·
4	2026-03-03	4	view ·
4	2026-03-03	4	view ·
4	2026-03-03	4	view ·
4	2026-03-03	4	view ·
10-K	2026-02-12	10-K	view ·
8-K	2026-02-12	8-K	view ·
8-K	2026-01-08	8-K	view ·
4	2026-01-05	4	view ·
4	2026-01-05	4	view ·
4	2026-01-05	4	view ·
8-K	2026-01-02	8-K	view ·
4	2025-12-22	4	view ·
4	2025-12-03	4	view ·
4	2025-12-03	4	view ·
10-Q	2025-11-04	10-Q	view ·
8-K	2025-11-04	8-K	view ·
4	2025-10-03	4	view ·
4	2025-10-03	4	view ·
4	2025-09-17	4	view ·
4	2025-09-04	4	view ·
4	2025-09-04	4	view ·
4	2025-09-04	4	view ·
4	2025-09-04	4	view ·
4	2025-08-21	4	view ·
4	2025-08-14	4	view ·
4	2025-08-14	4	view ·
10-Q	2025-08-05	10-Q	view ·
8-K	2025-08-05	8-K	view ·
4	2025-07-01	4	view ·
4	2025-07-01	4	view ·
8-K	2025-06-17	8-K	view ·

About AMWL

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. …

Options picks · AMWL

ITM + OTM ideas from the latest scan

Loading…

Congress trades · AMWL

STOCK Act disclosures

Loading…

SEC filings & insiders · AMWL

EDGAR · live

Loading…

Holders · AMWL

Institutions & insider activity

Loading…

American Well Corporation AMWL

Price chart

Latest bar · AMWL

Financial overlay · last 12 quarters

Compare AMWL vs peers

Earnings replay · last 20 reports

Peer comparison · Healthcare

Ownership

Top institutional holders

Insider activity · 90d

Analyst estimates

SEC filings

About AMWL

Options picks · AMWL

Congress trades · AMWL

SEC filings & insiders · AMWL

Holders · AMWL

Filing summary